Antibiotic treatment in community and hospital acquired pneumonia complicated by Clostridium difficile infection.

k. zycinska (Warsaw, Poland)

Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Session: Pleural diseases and pneumonia: what's new ?
Session type: Poster Discussion
Number: 1976
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
k. zycinska (Warsaw, Poland). Antibiotic treatment in community and hospital acquired pneumonia complicated by Clostridium difficile infection.. 1976

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pneumonia and Clostridium difficile infection: Hospital acquired infection in a non-ICU department
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Antibiotic management of nosocomial pneumonia in children
Source: Eur Respir J 2006; 28: Suppl. 50, 633s
Year: 2006

Analysis of antibiotic resistance and enterococcal infections of low respiratory infection on patients in hospital
Source: Eur Respir J 2003; 22: Suppl. 45, 450s
Year: 2003

General evaluation in cases with community acquired pneumonia due to C. pneumoniae
Source: Eur Respir J 2007; 30: Suppl. 51, 677s
Year: 2007

Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia?
Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Year: 2012


Emergency treatment of communityacquired pneumonia
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183
Year: 2006

Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis
Source: Eur Respir J 2015; 45: 1353-1363
Year: 2015



Streptococcus pneumoniae resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006



Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group
Source: Eur Respir J 2004; 24: Suppl. 48, 714s
Year: 2004

Profile of the respiratory patients with nosocomial Clostridium difficilae enterocolitis
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



The approach to antibiotic treatment in community-acquired pneumonia
Source: Annual Congress 2008 - MP14 - The approach to antibiotic treatment in community-acquired pneumonia
Year: 2008

Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004

Epidemiology, treatment and outcomes of nosocomial pneumonia due to Gram-negative bacteria
Source: Eur Respir J 2007; 30: Suppl. 51, 408s
Year: 2007

Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Source: Eur Respir J 2003; 21: 741-742
Year: 2003


Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007



Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009



Antibiotics and new guidelines for the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=175
Year: 2004

Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of S. pneumoniae
Source: Eur Respir J 2006; 28: Suppl. 50, 165s
Year: 2006